EICHORCondition: Atherosclerosis · Coronary Artery Disease · Sponsor: Beijing Inno Medicine Co., Ltd.
This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.
This description comes directly from the study's public registry record.
Jingmei Zhang, Master · 0086 010 82599080 · zhangjingmei@innovmedicine.com
Kaiqi Zong, Master · 0086 010 82599080 · zongkaiqi@innovmedicine.com
Always discuss trial participation with your own doctor first.
| Heart Center Research, LLC | Huntsville, Alabama, United States | Not Yet Recruiting |
| Clinical Trials Research | Lincoln, California, United States | Not Yet Recruiting |
| Stanford University School of Medicine | Stanford, California, United States | Not Yet Recruiting |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance, California, United States | Not Yet Recruiting |
| Excel Medical Clinical Trials dba Flourish Research - Boca Raton | Boca Raton, Florida, United States | Not Yet Recruiting |
| HCA Florida Heart Institute | Petersburg, Florida, United States | Not Yet Recruiting |
| Southern Illinois University School of Medicine | Springfield, Illinois, United States | Not Yet Recruiting |
| Midwest Heart & Vascular Specialists | Overland Park, Kansas, United States | Not Yet Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Not Yet Recruiting |
| Wake Forest University Health Sciences | Winston-Salem, North Carolina, United States | Not Yet Recruiting |
| The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital | Cincinnati, Ohio, United States | Not Yet Recruiting |
| Capital Area Research | Camp Hill, Pennsylvania, United States | Not Yet Recruiting |
+ 16 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07521007